Teva sees innovative revenue potential of $6 billion to $7 billion by 2030
TEVA•Teva expects innovative revenue potential of $6 billion to $7 billion and free cash flow of more than $3.5 billion by 2030. It expects total revenue to grow at a mid-single-digit rate from 2026 to 2030.
1. 2030 targets
Teva sees innovative revenue potential of $6 billion to $7 billion and targets free cash flow of more than $3.5 billion by 2030. The company expects total revenue to grow at a mid-single-digit rate from 2026 to 2030.
